Kyung Jin Kim,Hangil Park,Yi Ding,April Zhang,Lihong Wang,Maximiliano Vasquez
申请号：
US15759471
公开号：
US20190352386A1
申请日:
2016.09.13
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention is directed toward neutralizing monoclonal antibodies to Vascular Endothelial Growth Factor (VEGF) and angiopoietin 2 (Ang-2), pharmaceutical compositions comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
